Bioneer Corporation (KOSDAQ:064550)

Market Cap	369.09B
Revenue (ttm)	288.67B
Net Income (ttm)	-19.88B
Shares Out	25.81M
EPS (ttm)	-771.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	54,266
Average Volume	127,221
Open	14,290
Previous Close	14,300
Day's Range	14,280 - 14,520
52-Week Range	13,450 - 35,550
Beta	-0.03
RSI	41.69
Earnings Date	Aug 14, 2025

About Bioneer

Bioneer Corporation operates as a biotechnology company in South Korea, the Americas, Europe, Asia, Africa, and internationally. The company offers PCR and RT-PCR, real-time PCR, RNAi, chemicals, plastic consumables, and buffer and solutions; and sample preparation, protein synthesis and purification, gene cloning, fluorescence dye and quencher, electrophoresis, genome-wide function, and magnetic separation services, as well as instruments for conventional PCR, real-time PCR, sample preparation, protein synthesis, centrifuge and vortex mixer, a...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1992
• Employees: 377
• Stock Exchange: KOSDAQ
• Ticker Symbol: 064550

Financial Performance

In 2024, Bioneer's revenue was 293.98 billion, an increase of 11.68% compared to the previous year's 263.24 billion. Losses were -20.58 billion, 94.4% more than in 2023.